EC4-24286-71472
4 vaccinations
13 coded responses
54 check-ins
13 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 130 / NY
- Registered
- 2021-01-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-28
Registered in v-safe
-
2021-01-28
Dose 1 — Pfizer-BioNTech
- 2021-01-28
- 2021-01-29
- 2021-01-30
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-11
-
2021-02-18
Dose 2 — Pfizer-BioNTech
- 2021-02-18
-
2021-02-19
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, DiarrheaAdult check-in
-
2021-02-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, NauseaAdult check-in
-
2021-02-21
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · Fever · NoneAdult check-in
-
2021-02-22
Survey response — days 1–6 daily, dose 2MedDRA: Feeling hot, Mass, Pain, Rash — Feeling: Good · Site: Pain, Redness, SwellingFree text: Developed a visible, mildly painful lump yesterday near injection site/where I have a mild rash; arm from that area up to the shoulder is also much warmer to the touch compared to the rest of my arm.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-23
Survey response — days 1–6 daily, dose 2MedDRA: Injection site erythema, Injection site mass, Injection site rash — Feeling: Good · Site: Pain, Redness, SwellingFree text: Still have a lump in same area as mild redness/rash near injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-24
Survey response — days 1–6 daily, dose 2MedDRA: Injection site mass, Injection site rash — Feeling: Good · Site: Redness, Swelling · HeadacheFree text: Lump and mild rash near injection site have lessened.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-25
Survey response — day 7, dose 2MedDRA: Injection site rash, Yellow skin — Feeling: Good · Site: SwellingFree text: Rash near injection site is virtually gone, lump still present but greatly reducedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-04
- 2021-03-11
- 2021-03-18
- 2021-03-25
- 2021-04-01
- 2021-05-20
- 2021-08-19
-
2021-10-02
Dose 3 — Pfizer-BioNTech
- 2021-10-02
-
2021-10-03
Survey response — days 1–6 daily, dose 3MedDRA: Injection site induration — Feeling: Good · Site: Pain, RednessFree text: Area around injection site is firm.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-04
Survey response — days 1–6 daily, dose 3MedDRA: Injection site induration — Feeling: Good · Site: Pain, RednessFree text: Area around injection site is still slightly firm to the touchMedDRA releases: 2024-11 · check-in free text available
-
2021-10-05
Survey response — days 1–6 daily, dose 3MedDRA: Injection site induration — Feeling: Good · Site: Pain, RednessFree text: Firmness around injection site nearly goneMedDRA releases: 2024-11 · check-in free text available
-
2021-10-06
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Itching · NoneAdult check-in
- 2021-10-07
- 2021-10-09
- 2021-10-16
- 2021-10-23
- 2021-10-30
- 2021-11-06
- 2021-11-13
- 2022-01-01
- 2022-04-02
- 2022-10-02
-
2022-10-29
Dose 4 — Pfizer-BioNTech
- 2022-10-29
-
2022-10-30
Survey response — days 1–6 daily, dose 4MedDRA: Injection site pain — Feeling: Good · Site: Pain, Redness, ItchingFree text: Tender at the site of injectionMedDRA releases: 2024-11 · check-in free text available
-
2022-10-31
Survey response — days 1–6 daily, dose 4MedDRA: Injection site erythema, Injection site mass, Injection site pain, Injection site warmth — Feeling: Good · Site: Pain, Redness, Swelling, ItchingFree text: Redness surface area has increased, area is still warm and tender to the touch, visible and palpable lump at injection site areaMedDRA releases: 2024-11 · check-in free text available
-
2022-11-01
Survey response — days 1–6 daily, dose 4MedDRA: Injection site erythema, Injection site mass, Injection site pruritus, Injection site warmth — Feeling: Good · Site: Pain, Redness, Swelling, ItchingFree text: Red area around injection site is still large, though not as vibrant. Still visible and palpable lump, though less so. Arm is still warm to the touch at injection site, and occasional mild itching still persists.MedDRA releases: 2024-11 · check-in free text available
-
2022-11-02
Survey response — days 1–6 daily, dose 4MedDRA: Erythema, Pruritus, Swelling, Tenderness — Feeling: Good · Site: Pain, Redness, Swelling, ItchingFree text: Itching, redness, tenderness, and swelling all noticeably reduced.MedDRA releases: 2024-11 · check-in free text available
-
2022-11-03
Survey response — days 1–6 daily, dose 4MedDRA: Adverse reaction — Feeling: Good · Site: Redness, ItchingFree text: Side effects are largely goneMedDRA releases: 2024-11 · check-in free text available
-
2022-11-04
Survey response — days 1–6 daily, dose 4MedDRA: Adverse reaction — Feeling: Good · Site: Redness, ItchingFree text: All side effects are nearly gone.MedDRA releases: 2024-11 · check-in free text available
- 2022-11-05
- 2022-11-12
- 2022-11-19
- 2022-11-26
- 2022-12-03
- 2022-12-10
- 2023-01-30
- 2023-04-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-28 | Pfizer-BioNTech | |
| 2 | 2021-02-18 | Pfizer-BioNTech | |
| 3 | 2021-10-02 | Pfizer-BioNTech | No |
| 4 | 2022-10-29 | Pfizer-BioNTech | No |
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Developed a visible, mildly painful lump yesterday near injection site/where I have a mild rash; arm from that area up to the shoulder is also much warmer to the touch compared to the rest of my arm.
Systemic reaction (other): Still have a lump in same area as mild redness/rash near injection site
Systemic reaction (other): Lump and mild rash near injection site have lessened.
Release 4 — day 7, dose 2
Systemic reaction (other): Rash near injection site is virtually gone, lump still present but greatly reduced
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Area around injection site is firm.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Area around injection site is still slightly firm to the touch
Systemic reaction (other): Firmness around injection site nearly gone
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Tender at the site of injection
Systemic reaction (other): Redness surface area has increased, area is still warm and tender to the touch, visible and palpable lump at injection site area
Systemic reaction (other): Red area around injection site is still large, though not as vibrant. Still visible and palpable lump, though less so. Arm is still warm to the touch at injection site, and occasional mild itching still persists.
Systemic reaction (other): Itching, redness, tenderness, and swelling all noticeably reduced.
Systemic reaction (other): Side effects are largely gone
Systemic reaction (other): All side effects are nearly gone.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Adverse reaction | · | · | ✓ |
| SRO | Erythema | · | · | ✓ |
| SRO | Feeling hot | ✓ | ✓ | ✓ |
| SRO | Injection site erythema | ✓ | ✓ | ✓ |
| SRO | Injection site induration | · | · | ✓ |
| SRO | Injection site mass | ✓ | ✓ | ✓ |
| SRO | Injection site pain | · | · | ✓ |
| SRO | Injection site pruritus | · | · | ✓ |
| SRO | Injection site rash | ✓ | ✓ | ✓ |
| SRO | Injection site warmth | · | · | ✓ |
| SRO | Mass | ✓ | ✓ | ✓ |
| SRO | Pain | ✓ | ✓ | ✓ |
| SRO | Pruritus | · | · | ✓ |
| SRO | Rash | ✓ | ✓ | ✓ |
| SRO | Swelling | · | · | ✓ |
| SRO | Tenderness | · | · | ✓ |
| SRO | Yellow skin | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release